Autogenous paneled femoral vein grafts for mycotic thoracic aortic aneurysms

Ningzhi Gu1, Eimaan Shergill2, D Kirk Lawlor1

  • 1Division of Vascular Surgery, University of British Columbia, Vancouver, British Columbia, Canada.

JTCVS Techniques
|October 20, 2025
PubMed
Abstract

Insights

Autogenous femoral vein (FV) repair is a safe and durable treatment for mycotic thoracic aortic aneurysms (MTAAs). This study found FV grafts were associated with better outcomes and lower mortality compared to prosthetic grafts.

Area of Science:

  • Cardiovascular Surgery
  • Vascular Surgery
  • Aortic Aneurysm Research

Background:

  • Mycotic thoracic aortic aneurysms (MTAAs) are rare but serious conditions.
  • Traditional management involves aortic resection and prosthetic graft reconstruction.
  • Autogenous femoral vein (FV) has emerged as an alternative repair material.

Purpose of the Study:

  • To describe the technique of autogenous FV repair for MTAA.
  • To compare the outcomes of FV repair versus prosthetic grafts for MTAA.
  • To evaluate the safety and durability of FV grafts in MTAA management.

Main Methods:

  • Single-center retrospective cohort study.
  • Patients with MTAA were divided into FV graft and prosthetic graft cohorts.
  • Perioperative and long-term outcomes were analyzed using logistic regression.

Main Results:

  • The FV cohort had higher rates of positive intraoperative cultures (90% vs 33.3%) and longer operative times.
  • A trend towards improved in-hospital (0% vs 33%) and long-term mortality (10% vs 55.6%) was observed in the FV cohort.
  • Patients receiving FV grafts were more likely to be discharged home (90% vs 44.4%).

Conclusions:

  • Autogenous FV repair is a safe and durable option for MTAA.
  • No in-hospital deaths occurred in the FV cohort.
  • No long-term complications related to FV graft repair were reported.